Health Care & Life Sciences » Biotechnology | Emisphere Technologies Inc.

Emisphere Technologies Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2012
2013
2014
2015
2016
Sales/Revenue
-
-
-
411.00
1,195.00
Cost of Goods Sold (COGS) incl. D&A
29.00
9.00
15.00
906.00
1,512.00
Gross Income
29.00
9.00
15.00
495.00
317.00
SG&A Expense
6,802.00
7,585.00
9,290.00
17,601.00
7,524.00
EBIT
6,831.00
7,594.00
9,305.00
18,096.00
7,841.00
Unusual Expense
8,110.00
8,433.00
11,872.00
13,916.00
9,138.00
Non Operating Income/Expense
10.00
10.00
-
-
-
Interest Expense
6,236.00
4,955.00
6,232.00
8,966.00
11,353.00
Pretax Income
4,902.00
20,911.00
27,399.00
40,966.00
10,041.00
Income Tax
2,974.00
28.00
2,019.00
585.00
-
Consolidated Net Income
1,928.00
20,939.00
25,380.00
40,381.00
10,041.00
Net Income
1,928.00
20,939.00
25,380.00
40,381.00
10,041.00
Net Income After Extraordinaries
1,928.00
20,939.00
25,380.00
40,381.00
10,041.00
Net Income Available to Common
1,928.00
20,939.00
25,380.00
40,381.00
10,041.00
EPS (Basic)
0.03
0.35
0.42
0.67
0.17
Basic Shares Outstanding
60,687.50
60,687.50
60,687.50
60,687.50
60,687.50
EPS (Diluted)
0.03
0.35
0.42
0.67
0.17
Diluted Shares Outstanding
60,687.50
60,687.50
60,687.50
60,687.50
60,687.50
EBITDA
6,802.00
7,585.00
9,290.00
18,082.00
7,829.00
Non-Operating Interest Income
45.00
81.00
10.00
12.00
15.00

About Emisphere Technologies

View Profile
Address
4 Becker Farm Road
Roseland New Jersey 07068
United States
Employees -
Website http://www.emisphere.com
Updated 07/08/2019
Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in developing new formulations of existing products and chemical entities, using Eligen Technology. Its product pipeline includes prescription drug and medical food product candidates. The company was founded in 1986 and is headquartered in Roseland, NJ.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.